STILL SEEKING OUTCOMES AFTER 6TH STOMA APPLIANCE SCHEME SCHEDULE REVIEW:
LOWER QUALITY OF LIFE AND OTHER HEALTH IMPACTS EXPERIENCED BY OSTOMATES
Matt Dalton
Chair, Stoma Industry Association
SEGMENT RELEASE
Filmed in Sydney, New South Wales | December 2024
A stoma is a surgically created opening in the abdomen to remove body waste, such as faeces and urine. Many conditions can require a stoma, including colorectal cancer, inflammatory bowel disease (IBD), Crohn’s disease and ulcerative colitis, bladder cancer, injury trauma, and congenital defects.
50,000 Australians have undergone the trauma and challenge of having a stoma inserted. Whilst the Australian Government invests in the appliances and products they need through the Stoma Appliance Scheme (SAS), this list is dated and doesn’t include as many of the products available in other countries. A new report commissioned by the Stoma Industry Association (SIA) shows Australia lagging countries such as the United Kingdom, Canada and Spain in supporting ostomates (people with a stoma).
The report found that the Quality of Life (QoL) for Australian ostomates is lower than other developed nations and the general community. The reason for this includes:
- Australia reimburses fewer products on the Stoma Appliance Scheme (SAS). The UK provides 60 per cent more, for example.
- Australian spending as a percentage of GDP is five times smaller than Canada, and three times smaller than the UK.
- There are fewer specialist nurses to support the patient population. According to the Australian Association of Stomal Therapy Nurses, “A Stomal Therapy Nurse (STN) specialises in the management of patients with faecal and urinary diversions. In addition, the STN is an expert in the management of difficult and draining wounds, fistulae, gastrostomies, acute and chronic wounds and associated skin care. In short, STNs can assist with advice and management of any stoma and wound issue, and may also provide continence advice.”
The report also details the daily challenges of Australian ostomates:
- 1 in 5 stoma patients isolate themselves from others
- 65 per cent of patients say their ability to work is negatively impacted
- 3 in 5 patients experience a reduction in intimacy
Stoma appliances and supporting products are subsidised by the Commonwealth funded scheme.
There have been five reviews of the SAS, none of which have been released. The current (sixth) review released earlier this year by the Australian Government.
Australian Health Journal spoke with the Stoma Industry Association Chair, Matt Dalton about the same access to products needed by 50,000 Australian ostomates and the quality of life as patients overseas.
-
Detection and prevention of Alzheimer’s Disease and Related Dementias
Professor Vicky Vass serves as the Chief Executive Officer of Alzheimer’s Research Australia, which is based in Perth, Western Australia. Australian Health Journal met with Professor Vass to hear of the organisation’s mission to solve the mysteries surrounding Alzheimer’s disease, and focus on detection as the key to their efforts.
-
Raising awareness, engagement and inclusion of Allied Health
Anita Hobson-Powell holds the position of Chief Allied Health Officer for the Australian Government within the Department of Health and Aged Care. With a background as an exercise physiologist and extensive experience leading allied health professional associations*, she has been entrusted with three main priorities. First, she aims to raise awareness about the significance of allied health professionals and their role in the healthcare system. This involves ensuring that decision makers and individuals engaging with health services understand the contributions of allied health professionals.
-
Recognising service in health regulation
In April 2023, Professor John Skerritt retired from his position of Deputy Secretary Health Products Regulation Group, a role he has been in since 2012. During his time at the TGA he had line responsibility for over 1200 staff involved in the regulation of therapeutic goods, regulation of gene technology and industrial chemicals and control of drug import, export and production.
At this year’s ARCS 2023 Conference, ARCS Australia CEO Dr Shanny Dyer paid tribute to Professor Skerritt and his service to the Australian health industry. She led a tribute with fellow industry heads, Elizabeth de Somer, CEO, Medicines Australia, Anne Harris, Managing Director, Pfizer Australia & New Zealand, Deon Schoombie, CEO, Consumer Healthcare Products Australia, Ian Burgess, CEO, Medical Technology Association of Australia and Arthur Brandwood, President ARCS Australia.
